|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
5R01CA208735-02
|
$730,063
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
3U54CA156734-08S1
|
$64,152
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202922-02
|
$242,408
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-13
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
4E-BP Mimetics as Chemical Probes for Studying Translational Control in Cancer
|
5R01CA202018-03
|
$354,563
|
GARNER, AMANDA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-04
|
$49,524
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$106,356
|
Mock, Beverly
|
CCR (NCI)
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP
|
1R03CA223099-01A1
|
$68,371
|
NOUBISSI, FELICITE
|
JACKSON STATE UNIVERSITY
|
|
A Novel LGR4 Oncogenic Signaling in Breast Cancer Progression and Metastasis
|
5R01CA204926-02
|
$362,569
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel Mouse Model for Uterine Leiomyoma
|
5R03CA219326-02
|
$80,000
|
WONG, KWONG KWOK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A Pathway of Tumor Suppression
|
5R01CA047296-30
|
$366,000
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A role for c-Abl/Arg in melanoma progression
|
3R01CA166499-05S1
|
$51,515
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
Adaptive regulation of cancer cell fate following oncogene inhibition
|
5R00CA194163-04
|
$249,000
|
FALLAHI-SICHANI, MOHAMMAD
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Admin supplement - Chemical Approaches to Cell Signaling Enzymes
|
3R01CA074305-24S1
|
$73,513
|
COLE, PHILIP
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AfrECC Consortium GWAS
|
ZIA CP000185 10796
|
$31,496
|
Dawsey, Sandy
|
DCEG (NCI)
|
|
Altered Proteoglycan Gene Expression and Cancer
|
5R01CA039481-31
|
$379,604
|
IOZZO, RENATO
|
THOMAS JEFFERSON UNIVERSITY
|
|
An ESC-GEMM platform for rapid melanoma mouse modeling
|
1R03CA227349-01
|
$86,000
|
KARRETH, FLORIAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
An integrated systems approach for incompletely penetrant onco-phenotypes
|
3U01CA215794-02S1
|
$71,286
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
An Integrated Systems Approach for Incompletely Penetrant Onco-phenotypes.
|
5U01CA215794-02
|
$445,618
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-14
|
$328,700
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$775,353
|
DuBois, Wendy
|
CCR (NCI)
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
5R01CA116468-14
|
$349,000
|
JONES, DAVID
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
|
Apoptotic Network Integrated at the Mitochondrion
|
5R01CA125562-10
|
$356,198
|
CHENG, EMILY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
ARF6 function in cancers driven by RAS hyperactivation
|
1K99CA230312-01
|
$129,824
|
YOO, JAE HYUK
|
UNIVERSITY OF UTAH
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-08
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Autophagy in Adhesion and Metastasis
|
5R01CA126792-09
|
$317,000
|
DEBNATH, JAYANTA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
B7H1 Mediated Immunosuppression in Glioma
|
5R01CA164714-06
|
$292,280
|
BLOCH, ORIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-05
|
$359,556
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BCR Signaling in ABC DLBCL
|
ZIA BC 011354
|
$112,802
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Bioinformatics: Characterizing Brain Tumor Data
|
ZIA BC 011784
|
$87,193
|
Gilbert, Mark
|
CCR (NCI)
|
|
Bioinformatics: Systems Biology of Pediatric Cancers
|
ZIA BC 011002
|
$351,207
|
Khan, Javed
|
CCR (NCI)
|
|
Biomolecular Recognition and Binding Mechanisms
|
ZIA BC 010441
|
$460,274
|
Nussinov, Ruth
|
CCR (NCI)
|
|
Brain Tumor Immunotherapy
|
ZIA BC 011714
|
$305,175
|
Gilbert, Mark
|
CCR (NCI)
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
3R01CA136512-08S1
|
$73,692
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-08
|
$515,452
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
Brd4 is an atypical kinase that regulates transcription
|
ZIA BC 011381
|
$228,251
|
Singer, Dinah
|
CCR (NCI)
|
|
Breaking the paradigm: RhoA as a tumor suppressor in cancer
|
5F31CA216965-02
|
$30,558
|
BLAKE, DEVON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
|
1R01CA217169-01A1
|
$414,944
|
JONES, DAVID
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
c-Abl-mediated Suppression of Breast Cancer Development and Metastasis
|
3R01CA177069-05S1
|
$75,000
|
SCHIEMANN, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
c-Met-induced Renalase: a novel therapeutic target for renal cancer
|
1R03CA219731-01A1
|
$88,500
|
BALAN, MURUGABASKAR
|
BOSTON CHILDREN'S HOSPITAL
|
|
c-Myc Function
|
ZIA BC 011465
|
$408,012
|
Levens, David
|
CCR (NCI)
|
|
c-Myc Targets in the Pathogenesis of Human Cancers
|
5R01CA057341-26
|
$549,764
|
DANG, CHI
|
WISTAR INSTITUTE
|
|
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
|
3R01CA118374-10S1
|
$69,420
|
RYEOM, SANDRA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites
|
5R01CA118374-10
|
$342,000
|
RYEOM, SANDRA
|
UNIVERSITY OF PENNSYLVANIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|